The Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 3358(E), dated 5th November, 2013, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable.

jftLVªh löa Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99 vlk/kj.k EXTRAORDINARY Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii) izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY la- 791] ubZ fnYyh] c``gLifrokj] ekpZ 27] 2014@pS=k 6] 1936 No. 791] NEW DELHI, THRUSDAY, MARCH 27, 2014/CHAITRA 6, 1936 jlk;u vkSj moZjd ea=ky; ¼vkS"k/k foHkkx½ ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ vkns'k ubZ fnYyh] 27 ekpZ] 2014 dk-vk-1922¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 eb]Z 2013 d s lkFk ifBr vk"Sk/k ¼dher fu;=a .k½ vkn's k] 2013 d s ijS k 4] 6] 11 vkjS 14 }kjk inz Rr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk-vk- 1358¼v½ fnukda 5 uoEcj] 2013 dk s vf/kØe.k djr s gq,] uhp s dh lkj.kh d s LrHa k ¼5½ e as fofufnZ"V vf/kdre dher dk s mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dkbs Z g]S dk s NkMs d+ j vf/kdre dher ds :i e as fu;r djrh g S A lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- DyksfVªektk+sy islkfjt+ 200 fexzk- 1 ils kfjt+ 13-31 uksV % ¼d½ mi;qZDr lkj.kh ds LraHk ¼5½ esa vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgha Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxk A ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSa A ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsa A 1401 GI/2014 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼?k½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgha Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼Ä½ mi;DZq r lkj.kh d s LrHa k ¼5½ e as fofufn"ZV vf/kdre dher d s fy, fofufn"ZV vulq fwpr fofufefZr;k as d s fofufn"ZV fofHkUu rjhds vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼p½ mi;DZq r vulq fwpr fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lpw h II ds QkWeZ III e as Hkjdj ,uihih, dk s gj frekgh dh fjikVs Z izLrqr djxs kA mi;qZDr vuqlfwpr fofufeZfr;k as d s fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r dfFkr lkj.kh e as n'kk;Z s vf/kdre eYw ; vkjS 'krk± s dk ikyu ugh a djrh g S rk s o s vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gSa] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 27th March, 2014 S.O. 922(E).—In exercise of the powers, conferred by paragraph 4, 6, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with No. S.O. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 3358(E), dated 5th November, 2013, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Scheduled Formulation Strength Unit Ceiling Price (Rs.) No. (1) (2) (3) (4) (5) 1. Clotrimazole Pessaries 200mg 1 Pessaries 13.31 Note : (a) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO, 2013. (b) The manufacturers may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3 (d) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (e) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (f) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production/import and sale of scheduled formulation in Form-III of Schedule-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of schedules formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1923¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 eb]Z 2013 d s lkFk ifBr vk"Sk/k ¼dher fu;=a .k½ vkn's k] 2013 d s ijS k 4] 6] 11 vkjS 14 }kjk inz Rr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk-vk- 2855¼v½ fnukad 20 flrEcj] 2013 dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as e as l s izR;ds dh] LFkkuh; dj] ;fn dkbs Z gS] dk s NkMs d+ j vf/kdre dher ds :i esa fu;r djrh gS A lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- fyXukdus gkbMªkDs ykjs kbM 2%$ 1 fefy 0-92 ,Mjsukykbu bUtsD'ku ,Mjsukykbu 1%200]000 uksV % ¼d½ mi;qZDr lkj.kh ds LraHk ¼5½ esa vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgha Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxk A ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSa A ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsa A ¼?k½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgha Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼Ä½ mi;DZq r lkj.kh d s LrHa k ¼5½ e as fofufn"ZV vf/kdre dher d s fy, fofufn"ZV vulq fwpr fofufefZr;k as d s fofufn"ZV fofHkUu rjhds vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼p½ mi;DZq r vulq fwpr fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lpw h II ds QkWeZ III e sa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlfwpr fofufeZfr;k sa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r dfFkr lkj.kh e as n'kk;Z s vf/kdre eYw ; vkjS 'krk± s dk ikyu ugh a djrh g S rk s o s vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gSa] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 923(E).—In exercise of the powers, conferred by paragraph 4, 6, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 2855(E), dated 20th September, 2013, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Scheduled Formulation Strength Unit Ceiling Price (Rs.) No. (1) (2) (3) (4) (5) 1. Lignocaine Hydrochloride + 2% + 1 ml 0.92 Adrenaline Injection Adrenaline 1:200,000 Note : (a) The manufacturers of above mentioned Scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO, 2013. (b) The manufacturers may add local taxes only if they have paid actually to the Government on the ceiling price mentioned in the column (5) of the above table. (c) The ceiling price for a pack of the Scheduled formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) All the existing manufacturers of above mentioned Scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (e) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 5 (f) The manufacturers of above said Scheduled formulation shall furnish quarterly return to the NPPA, in respect of production/import and sale of scheduled formulation in Form-III of Schedule-II of the DPCO, 2013. Any manufacturer intending to discontinue above said Scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of schedules formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of ceiling price of the Scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1924¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a kky;] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k ¼ftldks lfa{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ es fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ es dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ luXyks QkekZL;wfVdYl izkbosV fyfeVsM vkSj eSllZ ,Ydse ysc- fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre [kqnjk ewY; ds #i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- esVQksjfeu ,plh,y$ esVQksjfeu ,plh,y&500 fexzk- 1 xksyh 8-47 okxs fyckls $ ¼lLVsUM fjfyt+ QkWeZ esa½ fxykbeijkbM xkfsy;ka okxs fyckls &0-3 fexzk- ¼xY;wdksfjy ,eoh 1@0-3½ fxykbeijkbM&1 fexzk- uksV % ¼d½ fofueZ krk mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ es fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsaA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdr dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kke Lo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 924(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s SunGlow Pharmaceuticals Pvt. Ltd. and M/ s Alkem Lab. Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Metformin HCl+ Metformin HCl– 500mg 1 Tablet 8.47 Voglibose + (As Sustained Release) Glimepiride Tablets Voglibose – 0.3mg (Glucoryl MV 1/0.3) Glimepiride– 1mg Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 7 (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1925¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a kky;] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k ¼ftldks lfa{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ es fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ luXyks QkekZL;wfVdYl izkbosV fyfeVsM vkSj eSllZ ,Ydse ysc- fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre [kqnjk ewY; ds #i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- esVQksjfeu ,plh,y$ esVQksjfeu ,plh,y&500 fexzk- 1 xksyh 10-46 okxs fyckls $ ¼lLVsUM fjfyt+ QkWeZ esa½ fxykbeijkbM xkfsy;ka okxs fyckls &0-3 fexzk- ¼xY;wdksfjy ,eoh 2@0-3½ fxykbeijkbM&2 fexzk- uksV % ¼d½ fofueZ krk mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ es fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsaA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdr dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA8 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kke Lo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 925(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. SunGlow Pharmaceuticals Pvt. Ltd. and M/s. Alkem Lab. Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Metformin HCl+ Metformin HCl– 500mg 1 Tablet 10.46 Voglibose + (As Sustained Release) Glimepiride Tablets Voglibose – 0.3mg (Glucoryl MV 2/0.3) Glimepiride– 2mg Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 9 (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer/marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1926¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a kky;] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k ¼ftldks lfa{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ ,dqEl MªXl ,aM QkekZL;wfVdYl fyfeVsM vkSj eSllZ T;wosUV~l gsYFkds;j fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 izR;sd vfyfir xksfy;ksa esa 1- fxykbeijkbM$ fxykbeijkbM&2 fexzk- 1 xksyh 4-50 esVQksjfeu ,plh,y xksfy;ka esVQksjfeu ,plh,y&500 fexzk- ¼VlQksjfeu Iyl½ uksV % ¼d½ fofueZ krk mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ es fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdr dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As10 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kke Lo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 926(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s Akums Drugs & Pharmaceuticals Ltd. and M/s Zuventus Healthcare Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each uncoated tablet contains 1. Glimepiride + Glimepiride– 2mg 1 Tablet 4.50 Metformin HCl Tablets Metformin HCL– 500 mg (Tusformin Plus) Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer/marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 11 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1927¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ ,dqEl MªXl ,aM QkekZL;wfVdYl fyfeVsM vkSj eSllZ T;wosUV~l gsYFkds;j fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 izR;sd vfyfir xksfy;ksa esa 1- fxfyDykTk+kbM$ fxfyDykTk+kbM&80 fexzk- 1 xksyh 4-63 esVQksjfeu ,plh,y xksfy;ka esVQksjfeu ,plh,y&500 fexzk- ¼VlQksjfeu th½ uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼Ä½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gSa] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd12 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 927(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Akums Drugs & Pharmaceuticals Ltd. and M/s. Zuventus Healthcare Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each uncoated tablet contains 1. Gliclazide + Gliclazide-80 mg 1 Tablet 4.63 Metformin HCl Tablets Metformin HCL– 500 mg (Tusformin G) Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer/marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 13 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1928¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh ifzof"V;k as e as fofufn"ZV icz yrk vkjS bdkb Z ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh ifzof"V e as elS l Z bukos k dis Vcs ikzboVs fyfeVsM vkSj eSllZ ekbØks yscl fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;k sa Øe'k% e sa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fyfir xksfy;ksa esa 1- lis kMs kDs lkbe izkDs lfsVy$ lis kMs kDs lkbe izkDs lfsVy 1 xksyh 12-91 vkW¶ykDs lhu xkfsy;ka lsiksMksDlkbe&200 fexzk- ds cjkcj ¼lis kMs kDs lkbe$vkW¶ykDs lhu½ vkW¶yksDlhu&200 fexzk- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ eas fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼Ä½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd14 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 928(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. AInnova Captab Pvt. Ltd. and M/s. Micro Labs Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Cefpodoxime Proxetil+ Cefpodoxime Proxetil eq. to 1 Tablet 12.91 Ofloxacin Tablets Cefpodoxime – 200 mg (Cefpodoxime+Ofloxacin) Ofloxacin– 200 mg Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 15 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1929¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ lsoh QkekZ vkSj eSllZ ,Ydse ysc fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- esVQksjfeu ,plh,y$ esVQksjfeu ,plh,y&850 fexzk- 1 xksyh 8-48 okxs fyckls $ ¼,DlVsaM fjfyt+ QkWeZ esa½ fxykbeijkbM xkfsy;ka okxs fyckls &0-2 fexzk- ¼xY;wdksfjy ,eoh 1 QksVZ½ fxykbeijkbM&1 fexzk- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ eas fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼Ä½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd16 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 929(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Savi Pharma and M/s. Alkem Lab Ltd. respectively. TABLE Sl. Name of the Schedule Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Metformin HCl + Metformin HCl - 850 mg 1 Tablet 8.48 Voglibose+ (As a Extended Release) Glimepiride Tablets Voglibose - 0.2 mg (Glucoryl MV 1 Forte) Glimepiride - 1 mg Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 17 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1930¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ lsoh QkekZ vkSj eSllZ ,Ydse ysc fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdZ kbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- esVQksjfeu ,plh,y$ esVQksjfeu ,plh,y&850 fexzk- 1 xksyh 10-46 okxs fyckls $ ¼,DlVsaM fjfyt+ QkWeZ esa½ fxykbeijkbM xkfsy;ka okxs fyckls &0-2 fexzk- ¼xY;wdksfjy ,eoh 2 QksVZ½ fxykbeijkbM&2 fexzk- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼Ä½ mi;qZDr xSj vf/kdr dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsaA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd18 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 930(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Savi Pharma and M/s. Alkem Lab Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Metformin HCl + Metformin HCl - 850 mg 1 Tablet 10.46 Voglibose+ (As a Extended Release) Glimepiride Tablets Voglibose - 0.2 mg (Glucoryl MV 2 Forte) Glimepiride - 2 mg Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer/marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 19 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1931¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ MkW- jsM~Mhl yscl fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdZ kbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd lLVsUM fjfyt xksfy;ksa esa 1- esVQksjfeu ,plh,y xksfy;ka esVQksjfeu ,plh,y&1000 fexzk- 1 xksyh 3-34 uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼Ä½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd20 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 931(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Reddy’s Lab Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each sustained release tablet contains 1. Metformin HCl Tablets Metformin HCl - 1000 mg 1 Tablet 3.34 Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 21 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1932¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh ifzof"V;k as e as fofufn"ZV icz yrk vkSj bdkb Z ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh ifzof"V e as eSll Z fØlUs V Fkjs kI;fwVDl fyfeVsM vkSj eSllZ xsYQk yscksjsVªht fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdZ kbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- ijS kflVkekys $ iSjkflVkeksy&325 fexzk- 1 xksyh 5-32 VªkekMksy ,plh,y xksfy;ka VªkekMksy gkbMªksDyksjkbM&37-5 fexzk- ¼FkeklZ Vs ½ uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd22 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 932(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Crescent Therapeutics Limited and M/s. Galpha Laboratories Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Paracetamol+ Paracetamol - 325 mg 1 Tablet 5.32 Tramadol HCl Tablets Tramadol Hydrochloride-37.5 mg (Thramacet) Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 23 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1933¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ esudkbaM QkekZ fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- ckblksizksyksy ¶;wekjsV$ ckblksizksyksy ¶;wekjsV&2-5 fexzk- 1 xksyh 5-08 ,eyksfMikbu cslkbysV xksfy;ka ,eyksfMikbu cslkbysV ,eyksfMikbu&5 fexzk- ds cjkcj uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd24 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 933(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Mankind Pharma Limited respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Bisoprolol Fumarate + Bisoprolol Fumarate - 2.5 mg 1 Tablet 5.08 Amlodipine Besilate Amlodipine Besilate eq. to Tablets Amlodipine – 5 mg Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 25 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1934¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ MkW- gsVsjks yscl fyfeVsM vkSj eSllZ bidk yscksjsVªhT+k fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- ,ftF+ kkzes kbflu$ ,ftF+ kzksekbflu ¼MkbZgkbZMªsV ds leku½ 1 xksyh 12-26 ysoks¶yksDlhu xksfy;ka ,ft+Fkzksekbflu&250 fexzk- ds cjkcj ¼,sthcsDV&,y 250a½ ysoks¶yksDlhu gsehgkbMªsV ysoks¶yksDlhu&250 fexzk- ds cjkcj D;w-,l- ,Dlhfi;UV~l uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd26 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 934(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Etero Labs Limited and M/s. IPCA Laboratories Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Azithromycin + Azithromycin (as dihydrate) 1 Tablet 12.26 Levofloxacin Tablets eq. to Azithromycin - 250 mg (Azibact –L 250) Levofloxacin Hemihydrate eq. to Levofloxacin -250 mg q.s excipients Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 27 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1935¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ eas fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh ifzof"V;k as e as fofufn"ZV icz yrk vkjS bdkb Z ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh ifzof"V e as elS l Z gVs js k s ycs l fyfeVMs vkSj eSllZ bidk yscksjsVªhT+k fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- ,ftF+ kkzes kbflu$ ,ftF+ kzksekbflu ¼MkbZgkbZMªsV ds leku½ 1 xksyh 21-77 ysoks¶yksDlhu xksfy;ka ,ft+Fkzksekbflu&500 fexzk- ds cjkcj ¼,sthcsDV&,y 500a½ ysoks¶yksDlhu gsehgkbMªsV ysoks¶yksDlhu&500 fexzk- ds cjkcj D;w-,l- ,Dlhfi;UV~l uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd28 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 935(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Hetero Labs Limited and M/s. IPCA Laboratories Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Azithromycin + Azithromycin (as dihydrate) 1 Tablet 21.77 Levofloxacin Tablets eq. to Azithromycin - 500 mg (Azibact –L 500) Levofloxacin Hemihydrate eq. to Levofloxacin -500 mg q.s excipients Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 29 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk-1936¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ eas fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh ifzof"V;k as e as fofufn"ZV icz yrk vkjS bdkb Z ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh ifzof"V e as elS l Z gVs js k s ycs l fyfeVMs vkSj eSllZ bidk yscksjsVªhT+k fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 izR;sd vfyfir ckbZys;MZ xksfy;ksa esa 1- esVQksjfeu ,plh,y$ esVQksjfeu ,plh,y&500 fexzk- 1 xksyh 8-46 fxykbeijkbM$ ¼lLVsUM fjfyt+ QkWeZ esa½ okxs fyckls xkfsy;ka fxykbeijkbM&1 fexzk- ¼Xyk;jh ,eoh 1½ oksxfycksl&0-2 fexzk- ,Dlhfi;UV~l D;w-,l- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd30 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 936(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s Hetero Labs Limited and M/s IPCA Laboratories Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each uncoated bilayered tablet contains 1. Metformin HCl+ Metformin HCl-500 mg 1 Tablet 8.46 Glimepiride+ (in sustained release form) Voglibose Tablets Glimepiride -1mg (Glyree MV1) Voglibose - 0.2 mg Excipients q.s. Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 31 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 937¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ ,dqEl MªXl ,aM QkekLZ ;fwVdYl ikzboVs fyfeVMs vkSj eSll Z lUs Vkjs QkekLZ ;fwVdYl ikzboVs fyfeVMs fuferZ vkSj foi.ku fofufn"ZV fofufefZr;k as Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd vfyfir ckbZys;MZ xksfy;ksa esa 1- esVQksjfeu ,plh,y$ esVQksjfeu ,plh,y&500 fexzk- 1 xksyh 8-46 fxykbeijkbM$ ¼lLVsUM fjfyt+ QkWeZ esa½ okxs fyckls xkfsy;ka fxykbeijkbM&1 fexzk- ¼fxfyehVsc ,eoh 1½ oksxfycksl&0-2 fexzk- ,Dlhfi;UV~l D;w-,l- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gaSA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd32 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 937(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s Akums Drugs & Pharmaceuticals Pvt. Ltd. and M/s. Centaur Pharmaceuticals Pvt. Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each uncoated bilayered tablet contains 1. Metformin HCl+ Metformin HCl-500 mg 1 Tablet 8.46 Glimepiride+ (in sustained release form) Voglibose Tablets Glimepiride -1mg (Glimitab MV1) Voglibose - 0.2 mg Excipients q.s. Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 33 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 938¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh ifzof"V;k as e as fofufn"ZV icz yrk vkjS bdkb Z ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh ifzof"V e as elS l Z gVs js k s ycs l fyfeVMs vkSj eSllZ bidk yscksjsVªht+ fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd vfyfir ckbZys;MZ xksfy;ksa esa 1- esVQksjfeu ,plh,y$ esVQksjfeu ,plh,y&500 fexzk- 1 xksyh 10-47 fxykbeijkbM$ ¼lLVsUM fjfyt+ QkWeZ esa½ okxs fyckls xkfsy;ka fxykbeijkbM&2 fexzk- ¼Xyk;jh ,eoh 2½ oksxfycksl&0-2 fexzk- ,Dlhfi;UV~l D;w-,l- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdr dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd34 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 938(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Hetero Labs Limited and M/s. IPCA Laboratories Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each uncoated bilayered tablet contains 1. Metformin HCl+ Metformin HCl-500 mg 1 Tablet 10.47 Glimepiride+ (in sustained release form) Voglibose Tablets Glimepiride -2mg (Glyree MV2) Voglibose - 0.2 mg Excipients q.s. Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer/marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 35 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 939¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ ,dqEl MªXl ,aM QkekLZ ;fwVdYl ikzboVs fyfeVMs vkSj eSll Z lUs Vkjs QkekLZ ;fwVdYl ikzboVs fyfeVMs fuferZ vkSj foi.ku fofufn"ZV fofufefZr;k as Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd vfyfir ckbZys;MZ xksfy;ksa esa 1- esVQksjfeu ,plh,y$ esVQksjfeu ,plh,y&500 fexzk- 1 xksyh 10-47 fxykbeijkbM$ ¼lLVsUM fjfyt+ QkWeZ esa½ okxs fyckls xkfsy;ka fxykbeijkbM&2 fexzk- ¼fxfyehVsc ,eoh 2½ oksxfycksl&0-2 fexzk- ,Dlhfi;UV~l D;w-,l- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gaSA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gaS] Lor% gh fujLr gks tk,axsaA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd36 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 939(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Akums Drugs & Pharmaceuticals Pvt. Ltd. and M/s. Centaur Pharmaceuticals Pvt. Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each uncoated bilayered tablet contains 1. Metformin HCl+ Metformin HCl-500 mg 1 Tablet 10.47 Glimepiride+ (In sustained release form) Voglibose Tablets Glimepiride -2mg (Glimitab MV2) Voglibose - 0.2 mg Excipients q.s. Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer/marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 37 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 940¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;k as e as fofufnZ"V izcyrk vkSj bdkbZ ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as eSllZ bUofsV~;k gYs Fkd;s j izkbosV fyfeVsM vkSj eSllZ ,Ydse yscksjsVªht+ fyfeVsM vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 1- fxfyDyk”kkbM$eVs Qkjs feu izR;sd vfyfir ckbZys;MZ xksfy;ksa ,plh,y xksfy;ka ¼b;wdykbM esa fxfyDyk”kkbM&¼30 fexzk-½ 1 xksyh 4-43 ,e 30 vksMh½ ¼l'a kkfs/kr fjfy”k Qke Z e½as eVs Qkjs feu ,plh,y&500 fexkz- ¼,DlVUsMMs fjfy”k Qke Z e½as ,Dlhfi;UV~l % D;w-,l- jax % jsM vkWDlkbM vkWQ vk;ju uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdr dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsaA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd38 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 940(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Inventia Healthcare Pvt. Ltd. and M/s. Alkem Laboratories Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each uncoated bilayered tablet contains 1. Gliclazide + Gliclazide - 30 mg 1 Tablet 4.43 Metformin HCl Tablets (in modified release form) (Euclide M 30 OD) Metformin HCl-500 mg (in extended release form) Excipients : q.s. Colour : Red Oxide of Iron Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer/marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 39 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 941¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh ifzof"V;k as e as fofufn"ZV icz yrk vkjS bdkb Z ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh ifzof"V e as elS l Z bukos k dis Vcs ikzboVs fyfeVsM vkSj eSllZ xsYQk yscksjsVªht+ fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd dksEch fdV esa 1- ¶Y;dw kus ktk+ys $ (i) izR;sd vfyfir xksfy;ksa esa 1 fdV ¼4 xksyh½ 86-70 ,ftFkkzes kbflu$ ¶Y;wdksukt+ksy&150 fexzk- dh ,d xksyh lsDuhMktk+sy dksEch fdV jax % iksufl;j 4vkj ¼¶Y;wdksu&,,l3 fdV½ (ii) izR;sd fQYe fyfir xksfy;ksa esa ,ftFkzksekbflu ¼MkbZgkbMªsV ds leku½ ,ftFkzksekbflu&1 xzke dh ,d xksyh jax % iksufl;j 4vkj (iii) izR;sd fQYe fyfir xksfy;ksa esa lsDuhMkt+ksy&1 xzke dh nks xksyh jax % VkbZVsfu;e MkbZvkWDlkbM uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA40 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsaA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 941(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Innova Captab Pvt. Ltd. and M/s. Galpha Laboratories Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each Combikit contains 1. Fluconazole + (i) Each uncoated tablet contains 1 Kit 86.70 Azithromycin+ One Tablet of Fluconazole-150 mg (4 Tablet) Secnidazole Combi Kit Colour : poncear 4R (Flucon-AS3 Kit) (ii) Each film coated tablet contains One Tablet of Azithromycin (as dihydrate) Eq. to Azithromycin-1 gm Colour : poncear 4R (iii) Each film coated tablet contains Two Tablets of Secnidazole -1 gm Colour : Titanium Dioxide Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 41 (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 942¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh ifzof"V;k as e as fofufn"ZV icz yrk vkjS bdkb Z ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh ifzof"V e as elS l Z bukos k dis Vcs ikzboVs fyfeVsM vkSj eSllZ esxusV yscl izkbosV fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds #i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd ?kqyus ds ckn 5 fefy lLisUlu esa 1- lsfQDlkbe vkWjy lLisUlu lsfQDlkbe VªkbZgkbMªsV ds leku 1 fefy 2-11 ¼MªkbZ flji½ ,UgkbMªsl lsfQDlkbe &100 fexzk- ds cjkcj ,Dlhfi;UV~l&D;-w,l- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gaSA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA42 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 942(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Innova Captab Pvt. Ltd. and M/s. Magnet Labs Pvt. Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each 5 ml of constituted suspension contains 1. Cefixime Oral Suspension Cefixime as Trihydrate 1 ml 2.11 (Dry Syrup) eq. to Anhydrous Cefixime -100 mg Excipients – q.s Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 43 (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 943¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ ;wfuD;ksj bafM;k fyfeVsM vkSj eSllZ vksclt+Z ck;ksVsd fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fQYe fyfir xksfy;ksa esa 1- gkbMªkDs lhDykjs kDs ohu gkbMªksDlhDyksjksDohu lYQsV&400 fexzk- 1 xksyh 10-12 lYQsV xksfy;ka jax % VkbZVsfu;e MkbZvkWDlkbM ,Dlhfi;UV~l&D;-w,l- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As44 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 943(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Unicure India Ltd. and M/s. Obsurge Biotech Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each film coated tablet contains 1. Hydroxychloroquine Hydroxychloroquine Sulphate-400mg 1 Tablet 10.12 Sulphate Tablets Colour : Titanium Dioxide Excipients – q.s Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 45 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 944¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ eas fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;k as e as fofufnZ"V izcyrk vkSj bdkbZ ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as eSllZ bUofsV~;k gYs Fkd;s j izkbosV fyfeVsM vkSj eSllZ ,Ydse yscksjsVªht+ fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZfr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd vfyfir ckbZys;MZ xksfy;ksa esa 1- fxfyDyktk+bM$ fxfyDyktk+bM&60 fexzk- 1 xksyh 6-88 esVQksjfeu ,plh,y xksfy;ka ¼la'kksf/kr fjfyt+ QkWeZ esa½ ¼b;wdykbM ,e 60 vksMh½ esVQksjfeu ,plh,y&500 fexzk- ¼,DlVsUMsM fjfyt+ QkWeZ esa½ ,Dlhfi;UV~l % D;w-,l- jax % jsM vkWDlkbM vkWQ vk;ju] ;syks vkWDlkbM vkWQ vk;ju uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gaSA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSaA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lpw uk ,uihih, dks voxr djk,xkA blds lEcU/k e sa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As46 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsaA ¹dk-a l-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 944(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Inventia Healthcare Pvt. Ltd. and M/s. Alkem Laboratories Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each Uncoated bilayered tablet contains 1. Gliclazide+ Gliclazide -60 mg 1 Tablet 6.88 Metformin HCl Tablets (in modified release form) (Euclide M 60 OD) Metformin HCl -500 mg (in extended release form) Excipients : q.s. Colour : Red Oxide of Iron, Yellow Oxide of Iron Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 47 (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 945¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 5] 11 vkSj 15 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh ifzof"V;k as e as fofufn"ZV icz yrk vkjS bdkb Z ¼;fwuV½ lfgr ml lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh ifzof"V e as elS l Z fufru ykbQ lkbla ls fyfeVMs vkjS elS l Z lhxy QkekLZ ;fwVdYl ikzboVs fyfeVMs fuferZ vkjS foi.ku fofufn"ZV fofufefZr;k as Øe'k% e as l s iRz ;ds dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vfèkdre [kqnjk ewY; ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 izR;sd fefy esa 1- MkbZlkbDyksekbu ,plh,y$ MkbZlkbDyksekbu ,plh,y&10 fexzk- 1 ,Ei;wy 8-06 fMDyksQsusd lksfM;e$ fMDyksQsusd lksfM;e&25 fexzk- ¼2 fefy½ csUtkWydksfu;e DyksjkbM csUtkWydksfu;e DyksjkbM lksY;w'ku&0-05% MCY;w@oh bUtDs 'ku ¼izsljosfVo ds leku½ ¼liq jLikl&vkj,Q½ bUtsD'ku ds fy, ikuh & D;w-,l- uksV % ¼d½ fofuekrZ k mi;DZq r nh xb Z fofufn"ZV QkWeyZw 's ku tk s Þub Z Mªxß Mhihlhvk]s 2013 d s ijS kxkzQ 2¼u½ d s rgr mi;DZq r nh xb Z lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;=a .k½ vkn's k] 2013 d s rgr vucq ) eYw ; fu/kkjZ .k@l'a kk/sku d s fy, QkeW Z I ij tek fd;k x;k Fkk vkjS ljdkj }kjk fuèkkfZjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA ¼p½ mi;DZq r fofufefZr;k as dh mRiknu@vk;kr vkjS fcØh d s lEcU/k e as lEcfU/kr fuekrZ kvk as dk s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn dju s dk bPNqd gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcU/k e as vxj fofufeZfr;kas ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekrZ k ;k foi.ku dEiuh] mijkDs r fofufefZr;k as vkjS fofufn"ZV 'krk± s dk ikyu ugh a djrh g aS rk s o s vko';d oLr,q ¡ vfèkfu;e] 1955 d s lkFk ifBr Mhihlhvk]s 2013 d s izko/kkuk as d s v/khu C;kt lfgr vf/kizHkkfjr jkf'k dk s tek dju s d s fy, nk;h gkxas As48 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsaA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 27th March, 2014 S.O. 945(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s. Nitin Life Sciences Ltd. and M/s. Seagull Pharmaceuticals Pvt. Ltd. respectively. TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) Each ml contains 1. Dicyclomine HCl+ Dicyclomine HCl-10 mg 1 Ampoule 8.06 Diclofenac Sodium+ Diclofenac Sodium - 25 mg (2ml) Benzalkonium Chloride Benzalkonium Chloride Solution - 0.05% w/v Injection (as preservative) (Superspas –RF) Water for Injections – q.s. Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production/import and sale in Form-III of Schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and/or import of above said formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer/marketer prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 49 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 946¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 1976¼v½ fnukad 6 vxLr] 2008 dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as e as l s izR;ds dh] LFkkuh; dj] ;fn dkbs Z gS] dk s NkMs d+ j vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ [kqnjk ewY; ¼#-½ 1 2 3 4 5 1- bC;wizksQsu flji 100 fexzk-@5 fefy 1 fefy 0-21 uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,xkA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgh Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkn's k e as mijkDs r lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as d s iSdk as dh vf/kdre dher fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd50 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 946(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 1976(E), dated 6th August, 2008, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Scheduled Formulation Strength Unit Ceiling Price No. (Rs.) (1) (2) (3) (4) (5) 1. Ibuprofen Syrup 100mg/5ml 1 ml 0.21 Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO,2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of Scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of Scheduled- II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 51 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 947¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 769¼v½ fnukda 10 vizSy] 2012 dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LrHa k ¼5½ es fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ es dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- iMsz fulkys kus xkfsy;ka 20 fexzk- 1 xksyh 1-72 uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,xkA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgh Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gaSA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkns'k es a mijksDr lkj.kh ds LrHa k ¼2½ es a dh rRLFkkuh izfof"V es a fofufnZ"V vuqlfwpr fofufeZr;ks a ds iSdks a dh vf/kdre dher fu;r gksus ds ifj.kke Lo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk,axsaA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd52 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 947(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 769(E), dated 10th April, 2012, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) 1. Prednisolone Tablets 20mg 1 Tablet 1.72 Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO,2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of scheduled- II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 53 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 948¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 444¼v½ fnukad 29 ekpZ] 2006 dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ es fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufefZr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- cSUTkkfFku cSUtk;yiSfulhfu bUtDs 'ku 12 yk[k ;wfuV 1 bUtsD'ku 11-07 uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,xkA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ eas vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgh Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkn's k e as mijkDs r lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as d s iSdk as dh vf/kdre dher fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsaA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh--IIº euh"k xksLokeh] mi-funs'kd54 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 948(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 444(E), dated 29th March, 2006, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Scheduled Formulation Strength Unit Ceiling Price No. (Rs.) (1) (2) (3) (4) (5) 1. Benzathine Benzylpenicillin Injection 12 lacs units 1 Injection 11.07 Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO, 2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of scheduled- II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 55 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 949¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 609¼v½ fnukad 27 ebZ] 2003 dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ eas dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- LVªsIVksekbflu lYQsV bUtsD'ku 1 xzke 1 bUtsD'ku 9-67 uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,xkA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ eas vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgh Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkn's k e as mijkDs r lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as d s iSdk as dh vf/kdre dher fu;r gksus ds ifj.kkeLo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsaA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh--IIº euh"k xksLokeh] mi-funs'kd56 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 949(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 609(E), dated 27th May, 2003, hereby fixes the prices as specified in column (5) of the Table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Scheduled Formulation Strength Unit Ceiling Price No. (Rs.) (1) (2) (3) (4) (5) 1. Streptomycin Sulphate Injection 1 gm 1 Injection 9.67 Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO,2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of scheduled- II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 57 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 950¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 1511¼v½ fnukda 1 tqykbZ] 2011 dk s vf/kØe.k djr s gq,] uhp s dh lkj.kh d s LrHa k ¼5½ e sa fofufnZ"V vf/kdre dher dk s mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- yos kMs kis k$dkfcMZ kis k xkfsy;ka yos kMs kis k&100 fexzk-$ 1 xksyh 1-44 dkfcMZ kis k&10 fexkz- uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,xkA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgh Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkn's k e as mijkDs r lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as d s iSdk as dh vf/kdre dher fu;r gksus ds ifj.kke Lo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsaA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd58 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 950(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 1511(E), dated 1st July, 2011, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) 1. Levodopa+ Carbidopa Tablets Levodopa-100mg+ 1 Tablet 1.44 Carbidopa-10mg Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO,2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of scheduled- II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/D.P./NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 59 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 951¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 1511¼v½ fnukda 1 tqykbZ] 2011 dk s vf/kØe.k djr s gq,] uhp s dh lkj.kh d s LrHa k ¼5½ e s fofufnZ"V vf/kdre dher dk s mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ es dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- yos kMs kis k$dkfcMZ kis k xkfsy;ka yos kMs kis k&250 fexzk-$ 1 xksyh 3-46 dkfcMZ kis k&25 fexkz- uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,xkA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ eas vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgh Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gaSA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkn's k e as mijkDs r lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as d s iSdk as dh vf/kdre dher fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd60 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 951(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 1511(E), dated 1st July, 2011, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Scheduled Formulation Strength Unit Retail Price No. (Rs.) (1) (2) (3) (4) (5) 1. Levodopa+ Carbidopa Tablets Levodopa-250mg+ 1 Tablet 3.46 Carbidopa-25mg Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO,2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of scheduled- II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 61 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 952¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 386¼v½ fnukad 2 vizSy] 2003 dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- ,flVkW;y lsyhflfyd ,sflM xksfy;ka 75 fexzk- 1 xksyh 0-26 lkYs ;cw y@?kyq u'khy uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,xkA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgha Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgha Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkn's k e as mijkDs r lkj.kh d s LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as d s iSdk as dh vf/kdre dher fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd62 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 952(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 386(E), dated 2nd April, 2003, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Schedule Formulation Strength Unit Ceiling Price No. (Rs.) (1) (2) (3) (4) (5) 1. Acetyl Salicylic Acid Tablets 75mg soluble/dispersible 1 Tablet 0.26 Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO, 2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of scheduled- II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 63 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 953¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 866¼v½ fnukad 16 vizSy] 2010 dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LrHa k ¼2½ e as dh rRLFkkuh izfof"V e as fofufnZ"V vuqlfwpr fofufeZfr;k as e as l s izR;ds dh] LFkkuh; dj] ;fn dkbs Z gS] dk s NkMs d+ j vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- flizk¶s ykDs lhu gkbMªkDs ykjs kbM vkW;UVeUs V 03% 1 xzke 1-06 uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,axkA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgha Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgha Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkns'k es a mijksDr lkj.kh ds LrHa k ¼2½ es a dh rRLFkkuh izfof"V es a fofufnZ"V vuqlfwpr fofufeZr;ks a ds iSdks a dh vf/kdre dher fu;r gksus ds ifj.kkeLo:i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gSa] Lor% gh fujLr gks tk;saxsA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd64 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 953(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 866(E), dated 16th April, 2010, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof TABLE Sl. Name of the Schedule Formulation Strength Unit Ceiling Price No. (Rs.) (1) (2) (3) (4) (5) 1. Ciprofloxacin 0.3% 1 gm 1.06 Hydrochloride Ointment Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraphs 13 (1) and 24 of the DPCO, 2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of Scheduled- II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 65 vkns'k ub Z fnYyh] 27 ekpZ] 2014 dk-vk- 954¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk- vk- 1394¼v½ rkjh[k 30 ebZ] 2013 d s lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkn's k] 2013 d s iSjk 4] 11 vkSj 14 }kjk iznRr 'kfDr;kas dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k la- dk- vk- 546¼v½ fnukad 10 ekpZ] 2011 dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ eas fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds :i esa fu;r djrh gSA lkj.kh Ø- la- vuqlwfpr fofufeZfr dk uke izcyrk bdkbZ vf/kdre dher ¼#-½ 1 2 3 4 5 1- tSUVkekbflu Mªkis 0-3% 1 fefy 0-89 uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gks tk,axhA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ es vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgha Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk ¼5½ esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼”k½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgha Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 13¼2½ ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhd s vkjS icz yrk l s fHkUu vxj ektS nw k fuekrZ kvk as }kjk ,d ub Z vk"Skf/k dk s ykpa djrk g S rk s ml s igy s vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s ijS kxkzQ 2¼u½ d s vulq kj vk"Sk/k ¼eYw ; fu;=a .k½ vkn's k] 2013 d s rgr lpw h II e as fofufn"ZV Qke Z I d s ekè;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa d s fuek.Z k dk s dkbs Z fuekrZ k mRiknu cUn dju s dk bPNdq gk s rk s bldh lpw uk ,uihih, dk s voxr djk;xs kA bld s lEcUèk esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkns'k es a mijksDr lkj.kh ds LrHa k ¼2½ es a dh rRLFkkuh izfof"V es a fofufnZ"V vuqlfwpr fofufeZr;ks a ds iSdks a dh vf/kdre dher fu;r gksus ds ifj.kke Lo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsaA ¹dk-al-a@144@12@2014@fo@Qk- l-a 8¼12½@2014@Mhih@,uihih,-&fMoh-&IIº euh"k xksLokeh] mi&funs'kd66 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 27th March, 2014 S.O. 954(E).—In exercise of the powers, conferred by paragraph 4, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 546(E), dated 10th March, 2011, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sl. Name of the Schedule Formulation Strength Unit Ceiling Price No. (Rs.) (1) (2) (3) (4) (5) 1. Gentamicin Drops 0.3% 1 ml 0.89 Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO, 2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO, 2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of Scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of Scheduled-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/144/12/2014/F/F. No. 8(12)/2014/DP/NPPA-Div.-II] MANISH GOSWAMI, Dy. Director Printed by the Manager, Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.